What is the recommended management for a 32-year-old primagravida (first pregnancy) at 7 weeks gestation with an ectopic pregnancy in the right fallopian tube, achieved through In Vitro Fertilization (IVF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ectopic Pregnancy in Right Fallopian Tube

The correct answer is B: Salpingotomy (or salpingectomy) of the right tube only. For this 32-year-old woman with a confirmed unruptured ectopic pregnancy in the right fallopian tube, the management should be either medical therapy with systemic methotrexate OR surgical management limited to the affected right tube—never hysterectomy, never bilateral salpingectomy, and never direct methotrexate injection into the tube. 1, 2, 3, 4, 5

Why Each Option is Correct or Incorrect

Option A: Hysterectomy - INCORRECT

  • Hysterectomy has absolutely no role in the management of tubal ectopic pregnancy 2, 3
  • The ectopic pregnancy is located in the fallopian tube, not the uterus 4, 5
  • This would unnecessarily eliminate all future fertility in a young primagravida who achieved pregnancy through IVF 6

Option B: Salpingotomy of Right Tube - CORRECT

  • This is the appropriate surgical approach for unruptured tubal ectopic pregnancy 4, 5, 7
  • Laparoscopic salpingotomy (linear incision with removal of ectopic and tube conservation) is performed when the contralateral tube is healthy 7
  • Alternatively, salpingectomy (complete removal of affected tube) is appropriate if the left tube is healthy 7
  • Surgical success rates approach 100% for unruptured ectopic pregnancies 3
  • Future fertility depends more on the condition of the contralateral (left) tube than on whether the right tube is conserved or removed 6

Option C: Salpingectomy of BOTH Tubes - INCORRECT

  • Removing both tubes would eliminate all future natural fertility 6
  • There is no indication to remove the unaffected contralateral tube 4, 5, 7
  • This would be devastating for a patient who already required IVF to conceive 6

Option D: Direct Methotrexate Injection into Tube - INCORRECT

  • The standard of care is systemic methotrexate (50 mg/m² IM), not direct injection into the fallopian tube 1, 3, 8
  • Direct injection into the tube is not part of established protocols 1, 3
  • While methotrexate can be injected directly into certain ectopic pregnancies in rare circumstances, this is not standard practice for tubal ectopics 7

Decision Algorithm: Medical vs. Surgical Management

Consider Medical Management (Systemic Methotrexate) If ALL Criteria Met:

  • Hemodynamically stable 1, 2, 3, 4, 5
  • Unruptured ectopic pregnancy 1, 3, 4, 5
  • Ectopic mass ≤3.5 cm in greatest dimension 1, 3
  • β-hCG levels ≤5,000 mIU/mL (preferably) 1, 2, 3
  • No embryonic cardiac activity on ultrasound 1, 3
  • Patient able and willing to comply with close follow-up 3
  • No contraindications (alcoholism, immunodeficiency, peptic ulcer disease, active lung/liver/kidney/hematologic disease) 1, 3

Proceed Directly to Surgery If ANY of the Following:

  • Hemodynamic instability or signs of rupture 1, 2, 3, 4, 5
  • β-hCG >5,000 mIU/mL (significantly increases failure risk to 22-29% with rupture rates of 17-19%) 2, 3
  • Ectopic mass >3.5-4 cm 1, 2, 3
  • Embryonic cardiac activity visualized 1, 2, 3
  • Significant hemoperitoneum (even if hemodynamically stable) 2
  • Patient unable to comply with follow-up 3
  • Absolute contraindications to methotrexate present 1, 3

Critical Information Missing from This Case

The question does not provide essential information needed to definitively choose between medical and surgical management:

  • β-hCG level (critical for determining methotrexate eligibility) 1, 2, 3
  • Size of ectopic mass (must be ≤3.5 cm for methotrexate) 1, 3
  • Presence or absence of fetal cardiac activity 1, 3
  • Hemodynamic stability 1, 2, 3, 4, 5
  • Presence of free fluid/hemoperitoneum 2

Surgical Technique When Surgery is Chosen

Laparoscopic approach is preferred over laparotomy whenever the patient is stable 7

Choice Between Salpingotomy vs. Salpingectomy:

  • Salpingotomy (tube-conserving): Performed when the contralateral left tube appears unhealthy or damaged 7
  • Salpingectomy (tube removal): Performed when the contralateral left tube is healthy 7
  • Future fertility outcomes are similar between both approaches 6, 7
  • Future fertility depends primarily on the condition of the contralateral tube, not the treatment method 6

Special Considerations for IVF Patients

  • This patient conceived through IVF, suggesting possible underlying tubal factor infertility 6
  • Risk of heterotopic pregnancy (coexisting intrauterine and ectopic pregnancy) is higher with assisted reproductive technologies 9
  • Ensure no intrauterine pregnancy coexists before proceeding with treatment 9
  • Approximately only one-third of women with ectopic pregnancy subsequently deliver a live-born infant, regardless of treatment method 6

Common Pitfalls to Avoid

  • Never perform hysterectomy for tubal ectopic pregnancy 2, 3
  • Never remove the unaffected contralateral tube 4, 5, 7
  • Do not use direct tubal injection of methotrexate as standard therapy—systemic IM administration is the established protocol 1, 3, 8
  • Do not attempt methotrexate without confirming eligibility criteria (stable, unruptured, appropriate size/hCG/no cardiac activity) 1, 2, 3
  • Methotrexate failure occurs in 3-36% of cases, with 12% requiring rehospitalization and potential rupture up to 32 days after treatment 1, 2, 3

References

Guideline

Methotrexate Dosing for Medical Management of Ectopic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ectopic Pregnancy Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Methotrexate Treatment for Unruptured Ectopic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.

Obstetrics and gynecology, 2018

Research

Tubal pregnancy: a review of current diagnosis and treatment.

Obstetrical & gynecological survey, 1998

Research

Tubal ectopic pregnancy: diagnosis and management.

Archives of gynecology and obstetrics, 2009

Research

Medical management of the patient with an ectopic pregnancy.

The Journal of perinatal & neonatal nursing, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.